SUNScholar - Browsing by Author "Maarman, G. J."

Now showing 1 - 2 of 2

Post-pulmonary tuberculosis complications in South Africa and a potential link with pulmonary hypertension : premise for clinical and scientific investigations
(Health & Medical Publishing Group, 2018) Allwood, Brian W.; Maarman, G. J.; Kyriakakis, C. G.; Doubell, A. F.
The magnitude of the pulmonary tuberculosis (TB) epidemic in South Africa (SA) and globally[1] has received increased attention. Efforts have been made to explore new and improved diagnostic[2] and treatment strategies,[3] but the story does not end with treatment, and TB frequently results in long-term lung damage.
Variation in HIV prevalence and the population-level effects of antiretroviral therapy in reducing tuberculosis incidence in South Africa
(Health & Medical Publishing Group, 2018) Sloot, R.; Maarman, G. J.; Osman, M.; Marx, F. M.
The current year (2018) marks the 10th year after the tuberculosis (TB) epidemic in South Africa (SA) reached a historic peak of 848 incident TB cases per 100 000 population in 2008.[1,2] TB incidence has since decreased at an average of 2.0% annually to 781 per 100 000 in 2016.[1,2] The decline observed in the past decade has mainly been attributed to the expansion of HIV testing and antiretroviral therapy (ART).[1,2] Despite these and other public health efforts, TB remains a leading cause of death in SA,[1] and at the current rate of decline, SA will not reach the 2035 targets of the End TB Strategy.